BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 28929537)

  • 1. The value of local registry data for describing cervical cancer management and outcomes over three decades in Australia.
    Roder D; Davy M; Selva-Nayagam S; Gowda R; Paramasivam S; Adams J; Keefe D; Eckert M; Powell K; Fusco K; Buranyi-Trevarton D; Oehler MK
    Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 28929537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using hospital registries in Australia to extend data availability on vulval cancer treatment and survival.
    Roder D; Davy M; Selva-Nayagam S; Paramasivam S; Adams J; Keefe D; Olver I; Miller C; Buckley E; Powell K; Fusco K; Buranyi-Trevarton D; Oehler MK
    BMC Cancer; 2018 Aug; 18(1):858. PubMed ID: 30165835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer treatment and survival: the experience of major public hospitals in south Australia over three decades.
    Roder D; Karapetis CS; Wattchow D; Moore J; Singhal N; Joshi R; Keefe D; Fusco K; Powell K; Eckert M; Price TJ
    Asian Pac J Cancer Prev; 2015; 16(6):2431-40. PubMed ID: 25824777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the added value of hospital-registry data for showing local service outcomes: cancers of the ovary, fallopian tube and peritoneum.
    Roder D; Davy M; Selva-Nayagam S; Paramasivam S; Adams J; Keefe D; Miller C; Powell K; Fusco K; Buranyi-Trevarton D; Oehler MK
    BMJ Open; 2019 Feb; 9(2):e024036. PubMed ID: 30782891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Female breast cancer management and survival: The experience of major public hospitals in South Australia over 3 decades-trends by age and in the elderly.
    Roder D; Farshid G; Kollias J; Koczwara B; Karapetis C; Adams J; Joshi R; Keefe D; Miller C; Powell K; Fusco K; Eckert M; Buckley E; Beckmann K; Price T
    J Eval Clin Pract; 2017 Dec; 23(6):1433-1443. PubMed ID: 28990314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can chemotherapy boost the survival benefit of adjuvant radiotherapy in early stage cervical cancer with intermediate risk factors? A population based study.
    Mahmoud O; Hathout L; Shaaban SG; Elshaikh MA; Beriwal S; Small W
    Gynecol Oncol; 2016 Dec; 143(3):539-544. PubMed ID: 27769525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic Colorectal Cancer Treatment and Survival: the Experience of Major Public Hospitals in South Australia Over Three Decades.
    Roder D; Karapetis CS; Wattchow D; Moore J; Singhal N; Joshi R; Keefe D; Fusco K; Buranyi-Trevarton D; Sharplin G; Price TJ
    Asian Pac J Cancer Prev; 2015; 16(14):5923-31. PubMed ID: 26320474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of chemoradiotherapy in cervical cancer--the Western Australian experience.
    Lim A; Sia S
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1431-8. PubMed ID: 21640504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
    Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan.
    Chen RJ; Lin YH; Chen CA; Huang SC; Chow SN; Hsieh CY
    Gynecol Oncol; 1999 May; 73(2):184-90. PubMed ID: 10329032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occult invasive cervical cancer found after inadvertent simple hysterectomy: is the ideal management: systematic parametrectomy with or without radiotherapy or radiotherapy only?
    Narducci F; Merlot B; Bresson L; Katdare N; Le Tinier F; Cordoba A; Fournier C; Leblanc E
    Ann Surg Oncol; 2015 Apr; 22(4):1349-52. PubMed ID: 25297903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiologic and Clinical Analysis of Cervical Cancer Using Data from the Population-Based Osaka Cancer Registry.
    Yagi A; Ueda Y; Kakuda M; Tanaka Y; Ikeda S; Matsuzaki S; Kobayashi E; Morishima T; Miyashiro I; Fukui K; Ito Y; Nakayama T; Kimura T
    Cancer Res; 2019 Mar; 79(6):1252-1259. PubMed ID: 30635276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distance from a Comprehensive Cancer Center: A proxy for poor cervical cancer outcomes?
    Barrington DA; Dilley SE; Landers EE; Thomas ED; Boone JD; Straughn JM; McGwin G; Leath CA
    Gynecol Oncol; 2016 Dec; 143(3):617-621. PubMed ID: 27720232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution in the management of locally advanced cervical cancer: the experience of Cancer Institute (WIA), Chennai, India.
    Shanta V; Selvaluxmy G; Swaminathan R; Shanthi P
    Asian Pac J Cancer Prev; 2010; 11(4):1091-8. PubMed ID: 21133630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benchmarking epidemiological characteristics of cervical cancer in advance of change in screening practice and commencement of vaccination.
    Luke C; Nguyen AM; Heard A; Kenny B; Shorne L; Roder D
    Aust N Z J Public Health; 2007 Apr; 31(2):149-54. PubMed ID: 17461006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Invasive cancer of the cervix. Treatment adapted as a function of the available therapeutic methods].
    Abboud J; Attieh E; Germanos A
    J Gynecol Obstet Biol Reprod (Paris); 1992; 21(1):19-22. PubMed ID: 1573216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women.
    Wang W; Hou X; Yan J; Shen J; Lian X; Sun S; Liu Z; Meng Q; Wang D; Zhao M; Qiu J; Hu K; Zhang F
    BMC Cancer; 2017 Aug; 17(1):510. PubMed ID: 28764676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of treatment factors and clinical outcomes in cervical cancer in older women compared to women under 65 years old.
    Diver EJ; Hinchcliff EM; Gockley AA; Melamed A; Contrino L; Feldman S; Growdon WB
    J Geriatr Oncol; 2018 Sep; 9(5):516-519. PubMed ID: 29503115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy.
    Hwang YY; Moon H; Cho SH; Kim KT; Moon YJ; Kim SR; Kim DS
    Gynecol Oncol; 2001 Jul; 82(1):88-93. PubMed ID: 11426967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of time interval between radical hysterectomy with pelvic node dissection and initial adjuvant therapy on oncological outcomes of early stage cervical cancer.
    Hanprasertpong J; Jiamset I; Geater A; Leetanaporn K; Peerawong T
    J Gynecol Oncol; 2017 Jul; 28(4):e42. PubMed ID: 28541633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.